1.
国家自然科学基金青年项目：超电荷聚多肽介导的
Cas9
蛋白选择性递释及其在治疗非小细胞肺癌中的应用，
81703402
，主持
2.
中国博士后基金面上资助：聚多肽与
Cas9
融合蛋白的构建及在肿瘤基因编辑中的应用，
2017M611957
，主持
3.
中国博士后特别资助项目：新型长效靶向抗耐药肿瘤蛋白
DNA
药物偶联物的开发，
2
019T120486
，主持
4.
江苏省自然科学基金面上项目：聚多肽融合
FGF21
蛋白调控肝巨噬细胞
Ly
6
C
表型转换在非酒精性脂肪性肝炎相关纤维化中的作用及机制研究，
BK
20221524
，主持
5.
重大新药创制科技重大专项：治疗非酒精性脂肪性肝炎新型生物药
PsTag600-FGF21
的研发，
2019ZX09201001-003-002
，参与排二
1.
Haichao Zhu#, Hong Luo#, Ruilong Chang, Yifan Yang, Dingkang Liu, Yue Ji, Hai Qin*, Haibo Rong*,
Jun Yin
*. Protein-based delivery systems for RNA delivery.
Journal of Controlled Release
. 2023, 363:253-274.
2.
Y
ue Ji#, Dingkang Liu#, Haichao Zhu, Lichen Bao, Ruilong Chang, Xiangdong Gao*,
Jun Yin
*. Unstructured Polypeptides as a Versatile Drug Delivery Technology.
Acta Biomaterialia
. 2023
,
164
:
74-93.
3.
Y
ifang Yang#, Haichao Zhu#, Dingkang Liu, Hong Luo, Ruilong Chang, Yue Ji, Wenbing Yao*,
Jun Yin
*, Xiangdong Gao*.
A Versatile Platform for the Tumor-Targeted Intracellular Delivery of Peptides, Proteins, and siRNA.
Advanced Functional Materials
.
2023, 2301011.
4.
Dingkang Liu#,
Lichen
Bao#
,
Haichao
Zhu
, Yue Ji,
Tian
Jing
, Xiangdong Gao*,
Jun Yin*
.
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy.
Journal of Controlled Release
. 2023, 354: 606-614.
5.
Dingkang Liu#, Ye Chen
#
, Qun Wang, Yue Ji, Lichen Bao, Wenbing Yao*, Xiangdong Gao*,
Jun Yin*
. Tailored protein-conjugated DNA nanoplatform for synergistic cancer therapy.
Journal of Controlled Release
. 2022, 346:250-259.
6.
Dingkang Liu#, Haibo Rong#, Ye Chen, Qun Wang, Sijia Qian, Yue Ji, Wenbing Yao*,
Jun Yin*
, Xiangdong Gao*. Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy.
British Journal of Pharmacology.
2022
,
179(13):3346-3362.
Qun Wang, Yifan Yang, Dingkang Liu, Yue Ji, Xiangdong Gao*,
Jun Yin
*, Wenbing Yao*.
